Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

964 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mapping the cellular response to small molecules using chemogenomic fitness signatures.
Lee AY, St Onge RP, Proctor MJ, Wallace IM, Nile AH, Spagnuolo PA, Jitkova Y, Gronda M, Wu Y, Kim MK, Cheung-Ong K, Torres NP, Spear ED, Han MK, Schlecht U, Suresh S, Duby G, Heisler LE, Surendra A, Fung E, Urbanus ML, Gebbia M, Lissina E, Miranda M, Chiang JH, Aparicio AM, Zeghouf M, Davis RW, Cherfils J, Boutry M, Kaiser CA, Cummins CL, Trimble WS, Brown GW, Schimmer AD, Bankaitis VA, Nislow C, Bader GD, Giaever G. Lee AY, et al. Among authors: han mk. Science. 2014 Apr 11;344(6180):208-11. doi: 10.1126/science.1250217. Science. 2014. PMID: 24723613 Free PMC article.
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial.
Singh D, Brightling CE, Rabe KF, Han MK, Christenson SA, Drummond MB, Papi A, Pavord ID, Molfino NA, Almqvist G, Kotalik A, Hellqvist Å, Gołąbek M, Sindhwani NS, Ponnarambil SS; COURSE study investigators. Singh D, et al. Among authors: han mk. Lancet Respir Med. 2024 Dec 6:S2213-2600(24)00324-2. doi: 10.1016/S2213-2600(24)00324-2. Online ahead of print. Lancet Respir Med. 2024. PMID: 39653044
GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.
Singh D, Stockley R, Anzueto A, Agusti A, Bourbeau J, Celli BR, Criner GJ, Han MK, Martinez FJ, Montes de Oca M, Ozoh OB, Papi A, Pavord I, Roche N, Salvi S, Sin DD, Troosters T, Wedzicha J, Zheng J, Volgelmeier C, Halpin D. Singh D, et al. Among authors: han mk. Eur Respir J. 2024 Dec 5:2401603. doi: 10.1183/13993003.01603-2024. Online ahead of print. Eur Respir J. 2024. PMID: 39638416
Associations between life-course FEV1/FVC trajectories and respiratory symptoms up to middle age: analysis of data from two prospective cohort studies.
Perret JL, Bui DS, Pistenmaa C, Vicendese D, Khan SS, Han MK, San José Estépar R, Lowe AJ, Lodge CJ, Labaki WW, Pham JV, Idrose NS, Senaratna CV, Tan DJ, Hamilton GS, Thompson BR, Munsif M, Arynchyn A, Jacobs DR Jr, Abramson MJ, Walters EH, Washko GR, Kalhan R, Dharmage SC; AUSCULTATE investigator group. Perret JL, et al. Among authors: han mk. Lancet Respir Med. 2024 Nov 27:S2213-2600(24)00265-0. doi: 10.1016/S2213-2600(24)00265-0. Online ahead of print. Lancet Respir Med. 2024. PMID: 39615504
Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung Volumes.
Arjomandi M, Zeng S, Barjaktarevic I, Bleecker ER, Bowler RP, Criner GJ, Comellas AP, Couper DJ, Curtis JL, Dransfield MT, Drummond MB, Fortis S, Han MK, Hansel NN, Hoffman EA, Kaner RJ, Kanner RE, Krishnan JA, Labaki W, Ortega VE, Peters SP, Rennard SI, Cooper CB, Tashkin DP, Paine R 3rd, Woodruff PG. Arjomandi M, et al. Among authors: han mk. Ann Am Thorac Soc. 2024 Nov 25. doi: 10.1513/AnnalsATS.202405-527OC. Online ahead of print. Ann Am Thorac Soc. 2024. PMID: 39586032
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
Sheth KN, Albers GW, Saver JL, Campbell BCV, Molyneaux BJ, Hinson HE, Cordonnier C, Steiner T, Toyoda K, Wintermark M, Littauer R, Collins J, Lucas N, Nogueira RG, Simard JM, Wald M, Dawson K, Kimberly WT; CHARM Trial investigators. Sheth KN, et al. Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3. Lancet Neurol. 2024. PMID: 39577921 Clinical Trial.
Respiratory Diseases in Women.
Han MK, Shteinberg M, Assayag D, Schleich F, Pengo M, Scicluna VM, Lombardi C, Barrecheguren M, Jara-Palomares L. Han MK, et al. Arch Bronconeumol. 2024 Nov 2:S0300-2896(24)00412-5. doi: 10.1016/j.arbres.2024.10.009. Online ahead of print. Arch Bronconeumol. 2024. PMID: 39572362 Review. English, Spanish.
Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider Insights.
Román-Rodríguez M, McMullan I, Warner M, Compton CH, Tal-Singer R, Orlow JM, Han MK. Román-Rodríguez M, et al. Among authors: han mk. Patient Prefer Adherence. 2024 Nov 14;18:2295-2306. doi: 10.2147/PPA.S467870. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 39559482 Free PMC article.
964 results